Pasithea Therapeutics Corp. (KTTA) stock
KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.07 (-13.14%)
Close on Nov 17, 2026Market cap $14.51MP/E –Yield –
Pasithea Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pasithea Therapeutics's enterprise value was -$27.89M on Nov 11, 2026, against $6.82M a year earlier. Over the last 5 years it ranged from -$39.12M to $6.82M, with a median of -$12.89M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$27.89M | -609.0% |
| 2025 | Dec 31, 2025 | $5.48M | – |
| 2024 | Dec 31, 2024 | -$6.07M | – |
| 2023 | Dec 29, 2023 | -$11.97M | – |
| 2022 | Dec 30, 2022 | -$25.34M | -1000.8% |
| 2021 | Dec 31, 2021 | $2.81M | – |
See a number that looks wrong?